Exclusive patent, know-how, and trademark license to use, market, promote, distribute and sell all dosage strengths and forms of the 'Histrelin Hydron Implant' containing histrelin acetate and sold in a kit with materials and accessories, for the treatment of prostate cancer, central precocious puberty (CPP) and other indications that may be developed, other than endometriosis.